StockData
Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc. (DNA) stock

DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3012% below fair value
$8.50−1.11 (-11.55%)

Close on Nov 16, 2026Market cap $572.39MP/E –Yield –

Ginkgo Bioworks total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Ginkgo Bioworks

Ginkgo Bioworks has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Ginkgo Bioworks figures

See a number that looks wrong?